Bacteriophages – a unique opportunity in the fight against antibiotic resistance
The report is a response to the challenge from Norwegian prime minister Erna Solberg. Many opportunities are available. Success can be achieved with commitment and right instruments.
Antibiotic resistance threatens the environment, animals, food production and public health
The threat posed by antibiotic resistance cannot be eliminated, but steps can be taken to reduce its progress.
Public health and modern medicine
Decades of medical research and progress could be reversed by antibiotic resistance.
Environmental consequences
The ecosystem in water, soil and organisms is disrupted by the production and use of pharmaceuticals and their subsequent disposal.
Antibiotics consumption in Norway
Norway is among the countries with the lowest consumption of antibiotics for both humans and animals, and has little problem with antibiotic resistance today.
Good experiences and many opportunities
Bacteriophages have a number of applications in such areas as human and veterinary medicine, aquaculture, agriculture and food processing.
Good experiences and many opportunities
In 2018, ACD Pharmaceuticals introduced CUSTUS®yrs as the world’s first bacteriophage product for use in aquaculture.
Bacteriophages – a unique opportunity in the fight against antibiotic resistance
The report is a response to the challenge from Norwegian prime minister Erna Solberg. Many opportunities are available. Success can be achieved with commitment and right instruments.
Bacteriophage production plant to open in 2022
ACD Pharma and sister company STIM are building the world’s first bacteriophage factory approved for pharmaceutical production, located alongside the companies’ new head offices.
